Article

Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease – Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin B

2023-06-23

Abstract excerpt

Cathepsin B is a cysteine protease that is implicated in multiple aspects of Alzheimer’s disease pathogenesis. The endogenous inhibitor of this enzyme, cystatin B ( CSTB) is encoded on chromosome 21. Thus, individuals who have Down syndrome, a genetic condition caused by having an additional copy of chromosome 21, have an extra copy of an endogenous inhibitor of the enzyme. Individuals who have Down syndrome are...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d03c5d24-2ec4-5a16-bfd7-150eba510779
DOI: 10.1101/2023.06.20.545700

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease – Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin BDOI 10.1101/2023.06.20.545700Read

Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease-Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin BSemantic proximity Read

Reduction of Cystatin B results in increased cathepsin B activity in disomic but not Trisomy21 human cellular and mouse modelsSemantic proximity Read

Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome-Alzheimer’s diseaseSemantic proximity Read

Comparison of the amyloid plaque proteome in Down syndrome, early-onset Alzheimer’s disease, and late-onset Alzheimer’s diseaseSemantic proximity Read

Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome–Alzheimer’s diseaseSemantic proximity Read

Aging in Down Syndrome and the Development of Alzheimer's Disease NeuropathologySemantic proximity Read

<i>β</i>-Secretases, Alzheimer’s Disease, and Down SyndromeSemantic proximity Read

Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study.Semantic proximity Read

From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approachSemantic proximity Read

Alzheimer's Disease in the Down Syndrome: An Overview of Genetics and Molecular AspectsSemantic proximity Read

Aging with Down Syndrome—Where Are We Now and Where Are We Going?Semantic proximity Read

Life-long overexpression of S100β in Down’s syndrome: implications for Alzheimer pathogenesisSemantic proximity Read